Puma Biotechnology | Gewinn Vor Steuern


Pre Tax Profit Veränderung
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
Biogen BIIB:US $ 874.8M 28.6M
Biomarin Pharmaceutical BMRN:US $ 34.85M 8.66M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Clovis Oncology CLVS:US $ -71.37M 11.08M
Daiichi Sankyo 4568:JP Y 29415M 81785M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Exelixis EXEL:US $ 88.51M 3.28M
Intercept Pharmaceuticals ICPT:US $ -20.32M 3.04M
Macrogenics MGNX:US $ -41.3M 25.14M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Novartis NOVN:VX SF 4129M 217M
Ptc Therapeutics PTCT:US $ -148.7M 26.8M
Sangamo Biosciences SGMO:US $ -43.09M 0.83M
Sarepta Therapeutics SRPT:US $ -228.09M 123.95M
Spectrum Pharmaceuticals SPPI:US $ -29.03M 13.65M
Takeda 4502:JP Y 155473M 209520M
Tg Therapeutics TGTX:US $ -40.51M 28.5M
Ultragenyx Pharmaceutical RARE:US $ -157.86M 6.1M
Vanda Pharmaceuticals VNDA:US $ 3.79M 11.35M



Puma Biotechnology Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.